Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Berirab P 300IU Injection
Manufacturer/Marketed By : BHARAT SERUMS & VACCINES LTD
$62.19 $49.75
Berirab P 300 IU Injection contains the active agent Human Rabies Immunoglobulin (HRIG). It is indicated to prevent passive, transient rabies infection after exposure to a rabid animal (dogs, mongoose,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
HUMAN RABIES IMMUNOGLOBULIN
Active Pharmaceutical Ingredient
Berirab P 300IU Injection
$62.19
$49.75
Berirab P 300 IU Injection contains the active agent Human Rabies Immunoglobulin (HRIG). It is indicated to prevent passive, transient rabies infection after exposure to a rabid animal (dogs, mongoose, jackals, foxes). This injection is formulated from blood plasma from screened donors. Rabies infection spreads when a person is bitten, scratched, or licked by an infected animal, especially when the skin is already injured. Rabies is a serious and often fatal viral disease that can cause severe neurological symptoms, including fever, headache, muscle weakness, and paralysis. Once symptoms develop, the disease is almost always fatal. Though this infection is 100% fatal, it is 100% preventable with timely measures and the correct use of available vaccines, immunoglobulins, or monoclonal antibodies. People with a history of severe allergic reactions to Berirab P 300IU Injection or any of its components should not receive this medication. This injection is prepared from human plasma and may contain infectious agents that can cause disease. Report to your physician immediately if you experience symptoms like headache, nausea, fever, vomiting, weakness, muscle pain, or diarrhea, as these symptoms indicate a possible viral infection. Pediatric patients require special considerations regarding the use of Berirab P 300IU Injection. It can be used in elderly individuals, but the dose and administration may need to be adjusted based on age, weight, and health status.
Active Pharmaceutical Ingredient
Uses
• Prevention of rabies infection post-exposure to a rabid animal
Benefits
The therapeutic effect of Berirab P 300IU Injection is to prevent or treat rabies infection. It works by providing immediate, passive immunity to the rabies virus by neutralizing the virus before it can infect the body's cells and cause disease. It is usually given along with the rabies vaccine, which helps the body develop its own antibodies against the virus.
Side Effects
Berirab P 300IU Injections cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Pain, swelling, or redness at the injection site
• Fever
• Headache
• Nausea
• Dizziness
Common Side Effects
• Severe allergic reactions
• Respiratory distress
• Blood pressure changes
• Seizures or convulsions
• Chest pain
• Unusual warmth of limb
How To Use
Berirab P 300IU Injection is administered as an injection, usually by a healthcare professional. The injection is typically given into the muscle or at the site of the bite wound.
Safety Advice
• Breast Feeding: It is unknown if Berirab P 300IU Injection is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking the injection.
• Alcohol: individuals should avoid consuming alcohol before or immediately after receiving Berirab P 300IU Injection, as alcohol can impair the immune system and potentially reduce the effectiveness of the treatment.
• Liver: Patients with preexisting liver disease should talk to their healthcare provider before taking it.
• Lungs: In individuals with lung conditions such as asthma or chronic obstructive pulmonary disease (COPD), Berirab P 300IU Injection can cause shortness of breath or worsen respiratory symptoms.
• Driving: Patients should always monitor their response to the Berirab P 300IU Injection medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: Pregnant women should consult their healthcare provider about their pregnancy status before receiving Berirab P 300IU Injection.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.